Related references
Note: Only part of the references are listed.Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis
Akimasa Takahashi et al.
CANCER CELL INTERNATIONAL (2014)
Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer
Yuanting Xiao et al.
TUMOR BIOLOGY (2014)
Glypican-3 as an emerging molecular target for hepatocellular carcinoma gene therapy
Min Yao et al.
TUMOR BIOLOGY (2014)
Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K/AKT pathway
Ying Zheng et al.
TUMOR BIOLOGY (2014)
Effects of AFP-activated PI3K/Akt signaling pathway on cell proliferation of liver cancer
Lu Zheng et al.
TUMOR BIOLOGY (2014)
Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling
Y. Feng et al.
CELL DEATH & DISEASE (2014)
Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
Tomoko Saito et al.
PLOS ONE (2013)
Regulation of L-Threonine Dehydrogenase in Somatic Cell Reprogramming
Chuanchun Han et al.
STEM CELLS (2013)
Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf-ERK-Nrf2 signaling and AMPK-independent pathways
Minh Truong Do et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Metformin, an Antidiabetic Agent Reduces Growth of Cutaneous Squamous Cell Carcinoma by Targeting mTOR Signaling Pathway
Sandeep C. Chaudhary et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2012)
ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma
Cheng-lin Yang et al.
TUMOR BIOLOGY (2012)
Inhibition of autocrine IGF-II on effect of human HepG2 cell proliferation and angiogenesis factor expression
Ninghua Yao et al.
TUMOR BIOLOGY (2012)
Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells
Zi-Miao Liu et al.
BIOCHEMICAL JOURNAL (2011)
Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: Role of Akt and nuclear factor-κB
Yong Ma et al.
CANCER LETTERS (2011)
Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
Guilherme Z. Rocha et al.
CLINICAL CANCER RESEARCH (2011)
Proteomic Analysis Identified DJ-1 as a Cisplatin Resistant Marker in Non-Small Cell Lung Cancer
Hua-Zong Zeng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
Elspeth M. Beauchamp et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer et al.
DIABETES CARE (2010)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase
Mahvash Zakikhani et al.
CANCER PREVENTION RESEARCH (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis
A. Isakovic et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial
Chia-Chi Lin et al.
INVESTIGATIONAL NEW DRUGS (2007)
Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells
Moon-Taek Park et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Inhibition by arsenic trioxide of human hepatoma cell growth
M Oketani et al.
CANCER LETTERS (2002)
Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: Inhibition of proliferation and induction of apoptosis
KPY Siu et al.
LIFE SCIENCES (2002)
Arsenic trioxide: Mechanisms of action
K Davison et al.
SEMINARS IN HEMATOLOGY (2002)
Share Paper
